Zhanguo Li

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Josef S Smolen, Robert Landewé, Sytske Anne Bergstra et al. · Annals of the Rheumatic Diseases · 2022 · 1.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Circulating Precursor CCR7loPD-1hi CXCR5+ CD4+ T Cells Indicate Tfh Cell Activity and Promote Antibody Responses upon Antigen Reexposure

Jing He, Louis M. Tsai, Yew Ann Leong et al. · Immunity · 2013 · 654 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Jing He, Xia Zhang, Yunbo Wei et al. · Nature Medicine · 2016 · 572 citations

Life Sciences, Immunology, Autoimmunity +15

Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis

Joel M. Kremer, Zhanguo Li, Stephen Hall et al. · Annals of Internal Medicine · 2013 · 447 citations

Medicine, Pharmacology, Pharmacotherapy +11